Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease

Movement Disorders

Volumn 12, Issue 1, 1997, Pages 103-106

  Zappia, Mario ^a   Montesanti, Rita ^a   Colao, Rosanna ^a   Branca, Damiano ^a   Nicoletti, Giuseppe ^a   Aguglia, Umberto ^a   Quattrone, Aldo ^a,b  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b Policlinico Mater Domini   (Italy)

Author keywords

Levodopa; Movement time; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOVEMENT (PHYSIOLOGY); ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROVOCATION TEST;

AGED; ANTIPARKINSON AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEVODOPA; LONG-TERM CARE; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, DOPAMINE;

EID: 0031025918     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120118     Document Type: Article

References (14)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
2. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
3. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992;55:1009-1013.
4. Hughes AJ, Lees AJ, Stern GM. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet 1990;336:32-34.
5. Hughes AJ, Lees AJ, Stern GM. Challenge test to predict the dopaminergic response in untreated Parkinson's disease. Neurology 1991;41:1723-1725.
6. D'Costa DF, Abbott RJ, Pye IF, Millac PAH. The apomorphine test in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 1991;54:870-872.
7. Gasser T, Schwarz J, Arnold G, Trenkwalder C, Oertel WH. Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neurol 1992;49:1131-1134.
8. Zappia M, Montesanti R, Colao R, Quattrone A. Usefulness of movement time in the assessment of Parkinson's disease. J Neurol 1994;241:543-550.
9. Fahn S, Elton RL, and the members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, eds. Recent developments in Parkinson's disease. London: Macmillan, 1987:153-163.
10. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(suppl):78-89.
11. Lees AJ. The Steele-Richardson-Olszewski syndrome. In: Marsden CD, Fahn S, eds. Movement disorders 2. London: Butterworth, 1987:272-287.
12. Fearnley JM, Lees AJ. Striatonigral degeneration: a clinicopathological study. Brain 1990;113:1823-1842.
13. Jackson JA, Jankovic J, Ford J. Progressive supranuclear palsy: clinical features and response to treatment. Ann Neurol 1983;13:273-278.
14. Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC. Clinically atypical expression of pathological typical Lewy body parkinsonism. Clin Neuropharmacol 1990;13:36-47.